Novo Nordisk Aktie

62,70 EUR -1,38 EUR -2,15 %

09:56:20

STU

59,79 CHF -1,07 CHF -1,76 %

09:50:12

BRX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.282,06 Mrd. EUR

KGV27,53Div. Rendite1,83%

WKNA3EU6F

ISINDK0062498333

SymbolNONOF

Novo Nordisk Aktien News

Sortieren:Datum Meistgelesen

10.08.23GlobeNewswireNovo Nordisk's sales increased by 29% in Danish kroner and by 30% at constant exchange rates to DKK 107.7 billion in the first six months of 2023

09.08.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

08.08.23GlobeNewswireNovo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial

31.07.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

24.07.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

17.07.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

10.07.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

03.07.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

26.06.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

19.06.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

12.06.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

12.06.23GlobeNewswireNovo Nordisk invests DKK 15.9 bn in expansion of manufacturing facilities in Hillerød, Denmark

06.06.23GlobeNewswireNovo Nordisk A/S – Share repurchase programme

05.06.23GlobeNewswireNovo Nordisk enters exclusive negotiations to acquire a controlling stake in BIOCORP, to be followed by a tender offer on all remaining shares

30.05.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

24.05.23GlobeNewswireNovo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discover and develop gene editing therapies for rare and cardiometabolic diseases

22.05.23GlobeNewswireNovo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial

22.05.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

15.05.23GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

15.05.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

10.05.23GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

09.05.23GlobeNewswireTrading in Novo Nordisk shares by board members, executives and associated persons

09.05.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

09.05.23GlobeNewswireNovo Nordisk A/S purchases B shares worth DKK 3,889 million from Novo Holdings A/S under the 2023 share repurchase programme

09.05.23GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

04.05.23GlobeNewswireNovo Nordisk's sales increased by 27% in Danish kroner and by 25% at constant exchange rates to DKK 53.4 billion in the first three months of 2023

03.05.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

28.04.23GlobeNewswireNovo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 28 April 2023

26.04.23GlobeNewswireNovo Nordisk A/S - Articles of Association

26.04.23GlobeNewswireNovo Nordisk A/S – Reduction of the share capital

24.04.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

17.04.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

13.04.23GlobeNewswireNovo Nordisk raises sales and operating profit outlook for 2023

12.04.23GlobeNewswireAspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity

03.04.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

27.03.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

24.03.23GlobeNewswireOral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial

23.03.23GlobeNewswireResolutions from the Annual General Meeting of Novo Nordisk A/S

20.03.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

14.03.23PR NewswireNovo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024

Novo Nordisk News

Novo Nordisk News: auf dieser Seite finden Sie alle Novo Nordisk News und Nachrichten zur Novo Nordisk Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.